Advances in Key Drug Target Identification and New Drug Development for Tuberculosis

Tuberculosis (TB) is a severe infectious disease worldwide. The increasing emergence of drug-resistant Mycobacterium tuberculosis (Mtb) has markedly hampered TB control. Therefore, there is an urgent need to develop new anti-TB drugs to treat drug-resistant TB and shorten the standard therapy. The d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Jie, Gong, Wenping, Wu, Xueqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896939/
https://www.ncbi.nlm.nih.gov/pubmed/35252448
http://dx.doi.org/10.1155/2022/5099312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896939/
https://www.ncbi.nlm.nih.gov/pubmed/35252448
http://dx.doi.org/10.1155/2022/5099312

Ejemplares similares